Who has invested in ImmuneOnco Biopharma?

Eli Lilly Asia Fund, LYFE Capital, Licheng Assets are named among the investors backing ImmuneOnco Biopharma.

ImmuneOnco Biopharma Funding: $25M Raised

ImmuneOnco Biopharma funding overview

ImmuneOnco Biopharma is based in Shanghai, China. ImmuneOnco Biopharma has raised $25M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for ImmuneOnco Biopharma runs through 2017; nothing later has been disclosed. Investors on record include Eli Lilly Asia Fund, LYFE Capital, Licheng Assets. 3 distinct backers are named across the disclosed rounds.

ImmuneOnco Biopharma at a glance

Total raised: $25M
Latest round date: January 2017
Headquarters: Shanghai, China
Notable investors: Eli Lilly Asia Fund, LYFE Capital, Licheng Assets

Frequently asked about ImmuneOnco Biopharma funding

How much has ImmuneOnco Biopharma raised?: ImmuneOnco Biopharma has raised $25M in total disclosed funding across the rounds on record.
Who has invested in ImmuneOnco Biopharma?: Eli Lilly Asia Fund, LYFE Capital, Licheng Assets are named among the investors backing ImmuneOnco Biopharma.
What was the latest ImmuneOnco Biopharma funding round?: No round stage has been disclosed for ImmuneOnco Biopharma.
Where is ImmuneOnco Biopharma based?: ImmuneOnco Biopharma is based in Shanghai, China.
When did ImmuneOnco Biopharma last raise?: The last disclosed ImmuneOnco Biopharma round closed in January 2017.

ImmuneOnco Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

ImmuneOnco Biopharma Funding: $25M Raised

ImmuneOnco Biopharma funding overview

ImmuneOnco Biopharma at a glance

Frequently asked about ImmuneOnco Biopharma funding

Companies related to ImmuneOnco Biopharma (18)

Browse related funding lists (4)